Journal article

Therapeutic Potential of Serotonin 5-HT3 Antagonists in Neuropsychiatric Disorders

KR Bentley, NM Barnes

CNS Drugs | Published : 1995


Serotonin 5-HT3-receptors are the only monoamine neurotransmitter receptors that are a member of the ligand-gated ion channel receptor superfamily, enabling these receptors to modulate fast synaptic transmission. Over the past 10 years, 5-HT3-receptors have been extensively investigated. Whilst it is generally accepted that 5-HT3-receptor antagonists attenuate emesis induced by a variety of stimuli, an extensive body of evidence indicates that these ligands may also alleviate some of the symptoms associated with various CNS disorders (e.g. psychosis, anxiety, dementia) and also reduce the rewarding properties of and withdrawal symptoms associated with drugs of abuse. In general, however, the..

View full abstract

Citation metrics